The BRAF proto-oncogene has recently been the focus of intensive research, as its mutation constitutively activates RAF/MEK signaling, a major driver of carcinogenesis in various malignancies, most notably in melanoma, colon cancer, and papillary thyroid cancer1. The gene discussed is BRAF; the disease is melanoma.